Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $1.1 Million - $1.59 Million
50,000 New
50,000 $1.12 Million
Q1 2020

May 15, 2020

SELL
$13.06 - $21.24 $705,240 - $1.15 Million
-54,000 Closed
0 $0
Q4 2019

Feb 12, 2021

SELL
$17.29 - $21.74 $8,645 - $10,870
-500 Reduced 0.92%
54,000 $1.1 Million
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $942,305 - $1.18 Million
54,500 New
54,500 $1.11 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.52B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.